Original Article

Should Increased Levels of Urinary 8-Hydroxydeoxyguanosine in Chronic Gastritis Imply Intestinal Metaplasia or Gastric Atrophy?

Authors: Fatih Albayrak, MD, Muhammet H. Uyanik, Hakan Dursun, Yavuz Albayrak, Sare Altas, Abdullah Uyanik, Serkan Cerrah, Yasin Bayir

Abstract

Objectives: Helicobacter pylori (H pylori) infection induces chronic inflammation that can progress to gastric atrophy, intestinal metaplasia, and gastric adenocarcinoma. We have examined oxidative damage caused by Helicobacter pylori, metaplasia, and atrophy of gastric mucosal cells in patients with chronic gastritis by measuring their urinary 8-hydroxydeoxyguanosine (8-OHdG) levels.


Methods: We recruited 77 outpatients with chronic gastritis, confirmed by endoscopic examination. H pylori status was evaluated by histology (modified Giemsa staining), the H pylori stool antigen test (n=20), and the 13C urea breath test (n=27), as described in the Maastricht consensus report.


Results: The mean amount of 8-OHdG (μg/g creatinine) in 77 subjects was 18.07 ± 13.49 x 10-3 μg/g creatinine. The levels of urinary 8-OHdG in the H pylori-positive gastritis patients were also significantly higher than those in the H pylori-negative gastritis patients (P=0.003, respectively, 20.42 ± 13.33 x 10-3 μg/g creatinine, 13.16 ± 12.71 x 10-3 μg/g creatinine). The level of urinary 8-OHdG was markedly higher in patients with gastric atrophy and intestinal metaplasia than in those without (P=0.000, P=0.002, respectively). There were significant correlations between levels of urinary 8-OHdG and both the atrophy score (r=0.441, P=0.000) and the intestinal metaplasia score (r=0.436, P=0.000).


Conclusions: Urinary 8-OHdG levels could be investigated in every patient with chronic gastritis, since it is a simple and completely noninvasive procedure. In patients with high levels of urinary 8-OHdG, endoscopic procedures or even pathological investigation may then be carried out, with the consideration that there is a high risk of intestinal metaplasia or atrophy.


Key Points


* Experience with urinary 8-OHdG for Helicobacter pylori, metaplasia, and atrophy of gastric mucosal cells is limited.


* Urinary 8-hydroxydeoxyguanosine (8-OHdG) can be used as a marker of generalized deoxyribonucleic acid (DNA) repair activity following oxidative damage.


* Urinary 8-OHdG levels could be investigated in every patient with chronic gastritis; it is a simple and completely noninvasive procedure.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65–69.
 
2. Noguchi K, Kato K, Moriya T, et al. Analysis of cell damage in Helicobacter pylori-associated gastritis. Pathol Int 2002;52:110–118.
 
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735–6740.
 
4.Nardone G, Staibano S, Rocco A, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999;44:789–799.
 
5. Ladeira MS, Rodrigues MA, Salvadori DM, et al. DNA damage in patients infected by Helicobacter pylori. Cancer Epidemiol Biomarkers Prev 2004;13:631–637.
 
6. Satoh K, Kimura K, Takimoto T, et al. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998;3:236–240.
 
7. Webb PM, Bates CJ, Palli D, et al. Gastric cancer, gastritis and plasma vitamin C: results from an international correlation and cross-sectional study. The Eurogast Study Group. Int J Cancer 1997;73:684–689.
 
8. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997;41:8–13.
 
9. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127–1131.
 
10. Farinati F, Cardin R, Bortolami M, et al. Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int J Cancer 2008;123:51–55.
 
11. Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 1996;5:627–630.
 
12. Lee BM, Jang JJ, Kim HS. Benzopyrene diol-epoxide-I-DNA and oxidative DNA adducts associated with gastric adenocarcinoma. Cancer Lett 1998;125:61–68.
 
13. Witherell HL, Hiatt RA, Replogle M, et al. Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct. Cancer Epidemiol Biomarkers Prev 1998;7:91–96.
 
14. Kim N, Park RY, Cho SI, et al. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol 2008;42:448–454.
 
15. Kang KP, Lee HS, Kim N, et al. Role of intestinal metaplasia subtyping in the risk of gastric cancer in Korea. J Gastroenterol Hepatol 2009;24:140–148.
 
16. Stemmermann GN. Intestinal metaplasia of the stomach. A status report. Cancer 1994;74:556–564.
 
17. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.
 
18. Hsu WY, Chen WT, Lin WD, et al. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta 2009;402:31–37.
 
19. Danese S, Cremonini F, Armuzzi A, et al. Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa. Scand J Gastroenterol 2001;36:247–250.
 
20. Farinati F, Cardin R, Russo VM, et al. Differential effects of Helicobacter pylori eradication on oxidative DNA damage at the gastroesophageal junction and at the gastric antrum. Cancer Epidemiol Biomarkers Prev 2004;13:1722–1728.
 
21. Farinati F, Della Libera G, Cardin R, et al. Gastric antioxidant, nitrites, and mucosal lipoperoxidation in chronic gastritis and Helicobacter pylori infection. J Clin Gastroenterol 1996;22:275–281.
 
22. Turkkan E, Uslan I, Acarturk G, et al. Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? J Gastroenterol 2009;44:66–70.
 
23. Shimizu T, Lee T, Shoji H, et al. Urinary 8-hydroxydeoxyguanosine excretion in children before and after therapy for eradication of Helicobacter pylori infection. Acta Paediatr 2003;92:1026–1028.